Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-05-09
2006-05-09
Wax, Robert A. (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600
Reexamination Certificate
active
07041644
ABSTRACT:
New therapeutic uses for BPI protein products that involve treatment of subjects with a BPI deficiency condition, including selective BPI deficiency, and newborns, including BPI-deficient newborns.
REFERENCES:
patent: 5827816 (1998-10-01), Theofan et al.
patent: 6153584 (2000-11-01), Levy
patent: 6376465 (2002-04-01), Levy
patent: WO 89/01486 (1989-02-01), None
patent: WO 98/06415 (1989-02-01), None
Elsbach “The ba ctericidal/permeability-increasing protein (BPI) in antibacterial host defense ”Jou. of Leukocyte Bio.64:14-18 (1998).
Levy et al., “Impaired Inn ate Immunity in the Newborn: Newborn Neutrophils are Deficient in Bactericidal/Permeability-Increasing Protein”Pediatrics104:1327-1333 (1999).
Wong et al., “Plasma Bactericidal/Permeability-Increasing Protein Concentrations in Critically Ill Children with the Sepsis Syndrome,”Pediatr. Dis. J., 14:1087-1097 (1995).
Anonymous, “Supplementation and Plasma Levels of Vitamin A in Premature Newborns at Risk for Chronic Ling Disease. Italian Collaborative Group on Preterm Delivery (ICGPD),”Dev. Pharm. and Therapeutics, 20:144-151 (1993).
Sands et al., “Epidemiology of Sepsis Syndrome in 8 Academic Medical Centers, ”JAMA, 278:234-240 (1997).
McCourt M., “At Risk for Infection: The Very Low Birthweight Infant,”J of Perinatal and Neonatal Nursing, 7:52-64 (1994).
Ammons et al., “An N-Terminal Fragment od Bactericidal/Permeability-Increasing Protein Protects Against Hemodynamic and Metabolic Derangements in Rat Gram-Negative Species,”J. Endotoxin Res., 3:57-66 (1996).
Dollard Anne
Laures Lily Rin
Mayer Suzanne M.
Wax Robert A.
XOMA Technology
LandOfFree
Therapeutic uses of BPI protein products in BPI-deficient... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic uses of BPI protein products in BPI-deficient..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic uses of BPI protein products in BPI-deficient... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3535054